9 Sep 2015 Activist investor Carl Icahn is jumping into the biopharma fray once again, this time getting involved with struggling obesity drugmaker Vivus. Exploring VIVUS (NASDAQ:VVUS) stock? View VVUS's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at StockTwits: https://stocktwits.com/DrTranBioSci. Harvest Exchange: If you need more information about Site or notice, please address Us using the following nals and NASDAQ's mobile application and incorporate posts from StockTwits, a communications platform for investors and the wider financial community. 5 May 2006 (NASDAQ:VVUS) today announced positive results from the pivotal Phase 3 clinical trial of Evamist(TM). VIVUS' investigational estradiol metered Rebound!! Under $10 $VVUS - up 329% $SGBX - up 138% $APM - up 23% $ PUMP - up 25% #Bdippr #Bdipprstocks #pennystocks #robinhoodapp # robinhood
VVUS: First Quarter 2020 Results: May 7: Edited Transcript of VVUS earnings conference call or presentation 6-May-20 8:30pm GMT: May 7: VIVUS, Inc's (VVUS) CEO John Amos on Q1 2020 Results - Earnings Call Transcript: May 6: Vivus EPS beats by $0.31, beats on revenue: May 6: VIVUS Reports First Quarter 2020 Financial Results: May 1
Real-time trade and investing ideas on Jack in the Box Inc. JACK from the largest community of traders and investors. Marker Therapeutics Inc. MRKR 2.21 0.03 (1.55%). NASDAQ Updated Jun 8, 2020 10:42 PM Sesen Bio, Inc. SESN 0.79 0.01 (0.80%). NASDAQ Updated Jun 8, 2020 11:58 PM
VIVUS, Inc. operates as a specialty pharmaceutical company primarily in the United States and the European Union. The company offers Qsymia for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body-mass index of 30 or greater (obese patients) or 27 or greater (overweight patients) in
Marker Therapeutics Inc. MRKR 2.21 0.03 (1.55%). NASDAQ Updated Jun 8, 2020 10:42 PM Sesen Bio, Inc. SESN 0.79 0.01 (0.80%). NASDAQ Updated Jun 8, 2020 11:58 PM iBio, Inc. IBIO 1.54 0.14 (10.00%). NYSEMkt Updated Jun 9, 2020 8:13 AM NASDAQ Updated Jun 8, 2020 8:31 PM. 71,329 Watchers. Watch • These 4 Stocks Prove that the Best Offense is a Good Defense • 4 "Big-Box" Retailers Built to Last • Why is Reity Now 32.5% Short the Market? Find the latest VIVUS, Inc. (VVUS) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
StockTwits: https://stocktwits.com/DrTranBioSci. Harvest Exchange: If you need more information about Site or notice, please address Us using the following
Current Technical Analysis and interactive chart for $VVUS stock / shares. See the current VVUS Ideas on StockTwits · VVUS Tweets on Twitter. Indicators
iBio, Inc. IBIO 1.54 0.14 (10.00%). NYSEMkt Updated Jun 9, 2020 8:13 AM
Market Data Disclaimer | © 2020 Seeking Alpha VIVUS (VVUS) Q3 Loss Narrower Than Expected, Revenues Up Y/Y. Zacks +19.65%. Nov-01-18 07:36PM : Vivus: 3Q Earnings Snapshot. Associated Press. 04:10PM : VIVUS Reports Third Quarter 2018 Financial Results. GlobeNewswire. Oct-29-18 07:30AM : VIVUS Adds Two New Members to the Board of Directors. Digital Ally, Inc. (DGLY), which develops, manufactures and markets advanced video recording products and other critical safety products for law enforcement, emergency management, fleet safety and Real-time trade and investing ideas on VIVUS Inc. VVUS from the largest community of traders and investors. $VVUS momentum continuing. Price up another 2.32% since last mention. First mentioned at 07:37 AM ET. Now trading at $3.53. #VVUS. Plus. TD BUY $VVUS at 3.67, Supp 3.67 Resis 4.33 R18 HiLo 42% T1Y 10 none fwdPE -1.4 DIV N/A #VIVUS, Inc #stocks #trading #finance #market http://bit.ly/ $VVUS $ITI $SLNO Make profit with good tread and best chatroom, join with us improve your skills and successful trade.. stocktwits.com/JessicaHoff/.